- ►washington.edu [PDF] DT Fleming, GM McQuillan, RE Johnson, AJ … - The New England journal of medicine, 1997 - nejm.highwire.org Results From 1988 to 1994, the seroprevalence of HSV-2 in persons 12 years of
age or older in the United States was 21.9 percent (95 percent confidence
interval, 20.2 to 23.6 percent), corresponding to 45 million infected ... Cited by 895 - Related articles - BL Direct - All 11 versions
- ►unm.edu [PDF] LR Stanberry, SL Spruance, AL Cunningham, DI … - The New England journal of medicine, 2002 - nejm.highwire.org 1652 · N Engl J Med, Vol. 347, No. 21 · November 21, 2002 · www.nejm.org ...
GLYCOPROTEIN-D–ADJUVANT VACCINE TO PREVENT GENITAL HERPES ... L AWRENCE R. S
TANBERRY , MD, P H .D., S POTSWOOD L. S PRUANCE , MD, A NTHONY L. C ... Cited by 379 - Related articles - BL Direct - All 11 versions
- ►washington.edu [PDF] A Wald, J Zeh, S Selke, RL Ashley, L Corey - The New England journal of medicine, 1995 - nejm.highwire.org Results During a median follow-up of 105 days, subclinical shedding of virus was
identified in 36 of 65 women (55 percent) with HSV type 2 (HSV-2), in 16 of 31
women (52 percent) with HSV type 1 (HSV-1) and HSV-2, and in 4 of 14 women ... Cited by 362 - Related articles - BL Direct - All 6 versions
- ►washington.edu [PDF] A Wald, J Zeh, S Selke, T Warren, AJ Ryncarz, … - The New England journal of medicine, 2000 - nejm.highwire.org Results HSV was isolated from the genital mucosa in 38 of the 53
HSV-2–seropositive subjects (72 percent) who reported no history of genital
herpes, and HSV DNA was detected by the polymerase-chain-reaction assay in ... Cited by 309 - Related articles - All 7 versions
AGM Langenberg, L Corey, RL Ashley, WP … - New England Journal of Medicine, 1999 - content.nejm.org Results The rates of new HSV-1 and HSV-2 infections were 1.6 and 5.1 cases per
100 person-years, respectively. Of the 155 new HSV-2 infections, 57 (37 percent)
were symptomatic, 47 of which (82 percent) were correctly diagnosed at ... Cited by 259 - Related articles - BL Direct - All 6 versions
A Wald, J Zeh, G Barnum, LG Davis, L Corey - Annals of Internal medicine, 1996 - Am Coll Physicians Objective: To assess the effect of the antiviral drug acyclovir on the frequency
of subclinical shedding of herpes simplex virus (HSV) in the genital tract. ...
Design: A double-blind, placebo-controlled, crossover clinical trial. Cited by 203 - Related articles - BL Direct - All 4 versions
- ►nih.gov RL Ashley, A Wald - Clinical Microbiology Reviews, 1999 - Am Soc Microbiol Prevention of genital herpes simplex virus (HSV) infections is desirable from
both a public health standpoint and the patient's perspective. A key factor in
the spread of genital herpes infections is the high proportion of ... Cited by 173 - Related articles - BL Direct - All 9 versions
- ►bmj.com RL Ashley - British Medical Journal, 2001 - sti.bmj.com This review will delineate performance characteristics and limitations, as far
as they are known, of the new glycoprotein G based, type specific HSV
serologies. Several of these tests have been FDA approved in the United ... Cited by 116 - Related articles - BL Direct - All 9 versions
TJ Brown, A Yen-Moore, SK Tyring - Journal of the American Academy of Dermatology, 1999 - Elsevier Sexually transmitted diseases are a persistent problem in the United States and
throughout the world. Many of these infections involve the skin and may be
encountered in the field of dermatology. This 3-part review highlights the ... Cited by 100 - Related articles - BL Direct - All 13 versions
SL Spruance, SK Tyring, B DeGregorio, C … - Archives of Internal Medicine, 1996 - archinte.highwire.org Background: Valaciclovir, the 1-valyl ester of acyclo- vir, has provided a
peroral acyclovir bioavailability 3 to 5 times that of acyclovir itself and is
rapidly and com- pletely converted to acyclovir by the liver. Accordingly, ... Cited by 100 - Related articles - BL Direct - All 5 versions
